G-CSF filgrastim biosimilar-Sandoz reduces the incidence of febrile neutropenia in patients receiving chemotherapy regimens with rest periods not exceeding 14 days: A French, multicenter, prospective, non-interventional study
- Resource Type
- Article
- Source
- In
Cancer Treatment and Research Communications 2023 35 - Subject
- Language
- ISSN
- 2468-2942